The question about CYP2D6 and stress lacks strong scientific support. CYP2D6 is a liver enzyme primarily involved in metabolizing many drugs (e.g., antidepressants, beta-blockers, opioids). Some research suggests it may also play a minor role in neurotransmitter metabolism (serotonin, dopamine), which could theoretically influence stress responses. However, direct evidence linking CYP2D6 genetic variants to perceived stress or stress resilience is very limited. The provided context does not contain relevant information on CYP2D6 and stress; the snippet about rs1800012 refers to the COL1A1 gene (collagen), not CYP2D6. Therefore, any claim that a DNA test can predict stress susceptibility via CYP2D6 is not evidence-based. Consumers should be cautious: genetic testing for CYP2D6 is useful for pharmacogenetics (drug dosing), but not for stress management. For stress, focus on lifestyle, sleep, exercise, and psychological support. Evidence grade: unclear.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-cf95d105217ff318738f4319